HealthQuill LDL Cholesterol
British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic disorder.
Drugs Health Medical

AstraZeneca in $1.92 million deal with HK-listed CSPC Pharmaceutical

British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic.

Read More
A simple blood test — done when women are in their 30s — can measure types of proteins in the blood that may shape heart diseases and aid physicians in early detection and treatment in the long run, a study finds.
Drugs Health Pharma

Simple blood tests can map women’s heart disease risks when done early

A simple blood test — done when women are in their 30s — can measure types of proteins in the blood that may.

Read More
Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia, projected to affect 153 million people by 2050.
Drugs Health Pharma

Untreated vision loss, high LDL cholesterol risk factors for dementia

Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia,.

Read More